Carnitine palmitoyltransferase II deficiency, severe infantile form (Q104474): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank

Revision as of 10:19, 17 August 2026

The severe infantile form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the early-onset form of the disease. Presentation can be in the newborn period but most cases have an age of onset between 6 and 24 months. The disease is characterised by a severe fasting intolerance leading to metabolic derangements of hypoketotic hypoglycaemia, resulting in coma and seizures, and hepatic encephalopathy leading to liver failure. There is associated skeletal muscle myopathy and cardiomyopathy which can lead to fatal paroxysmal cardiac arrhythmias.
Language Label Description Also known as
default for all languages
ID_1488785910
    English
    Carnitine palmitoyltransferase II deficiency, severe infantile form
    The severe infantile form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the early-onset form of the disease. Presentation can be in the newborn period but most cases have an age of onset between 6 and 24 months. The disease is characterised by a severe fasting intolerance leading to metabolic derangements of hypoketotic hypoglycaemia, resulting in coma and seizures, and hepatic encephalopathy leading to liver failure. There is associated skeletal muscle myopathy and cardiomyopathy which can lead to fatal paroxysmal cardiac arrhythmias.

      Statements

      CID11:ID_1488785910
      0 references
      dki-india-ID_1488785910
      0 references
      Concluído
      0 references